# An Extension Study of EV-BR1701 Part A1

> **NCT07635966** · — · COMPLETED · sponsor: **Enimmune Corporation** · enrollment: 180 (actual)

## Conditions studied

- Enterovirus Infections

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07635966
- **Lead sponsor:** Enimmune Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2025-09-20
- **Primary completion:** 2025-12-27
- **Final completion:** 2026-04-22
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2026-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07635966

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07635966, "An Extension Study of EV-BR1701 Part A1". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07635966. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*